InnoUp is a clinical stage company specialized in nanotechnology innovations, engaged in the development of oral drug delivery solutions. It has developed a Nanoparticle Platform that is protected by international patents.
InnoUp has 2 programs currently at clinical stage: an oral Peanut Allergy Vaccine (INP20) and an Oral Paclitaxel to treat Breast Cancer (INP12). It has an extensive network of collaborators from universities and research centers to take advantage of the most cutting-edge discoveries.
